NPRNPR·3hHealth
score+0.60
FDA panel considers easing peptide restrictions
Original
FDA panel considers easing peptide restrictions
“Forward-looking language ('considers,' 'pave the way') emphasizes potential regulatory relief and expanded access without sensationalism.”